AVITA Medical Inc
RCEL3.440USD
+0.010+0.29%
Close 12/23, 16:00（ET）Quotes delayed by 15 min
524.48MMarket Cap
LossP/E TTM
More Details of AVITA Medical Inc Company
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
AVITA Medical Inc Info
Ticker SymbolRCEL
Company nameAVITA Medical Inc
IPO dateMar 18, 2012
CEOVance (Cary G)
Number of employees260
Security typeOrdinary Share
Fiscal year-endMar 18
Address28159 Avenue Stanford
CityVALENCIA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code91355
Phone16613679170
Websitehttps://www.avitamedical.com/
Ticker SymbolRCEL
IPO dateMar 18, 2012
CEOVance (Cary G)
Company Executives of AVITA Medical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
17.90M
97.17%
Japan
427.00K
2.32%
United Kingdom
55.00K
0.30%
Australia
40.00K
0.22%
European Union (Region)
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Dec 4
Updated: Thu, Dec 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
4.48%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
Other
89.02%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
4.48%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
Other
89.02%
Shareholder Types
Shareholders
Proportion
Investment Advisor
10.47%
Investment Advisor/Hedge Fund
4.55%
Individual Investor
0.80%
Research Firm
0.74%
Hedge Fund
0.62%
Pension Fund
0.25%
Bank and Trust
0.24%
Venture Capital
0.08%
Other
82.25%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
206
7.68M
25.17%
-2.00M
2025Q2
210
7.20M
27.22%
-1.82M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
2023Q2
206
8.16M
32.08%
-1.08M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
1.45M
5.45%
+16.54K
+1.15%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.74M
6.53%
+13.93K
+0.81%
Jun 30, 2025
State Street Investment Management (US)
528.78K
1.99%
+1.83K
+0.35%
Jun 30, 2025
Geode Capital Management, L.L.C.
618.34K
2.32%
-1.36K
-0.22%
Jun 30, 2025
Northern Trust Investments, Inc.
242.03K
0.91%
-10.13K
-4.02%
Jun 30, 2025
Millennium Management LLC
369.19K
1.39%
+357.21K
+2980.45%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 3000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
View more
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.02%
iShares Micro-Cap ETF
Proportion0.01%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
iShares Russell 3000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
iShares Russell 2000 ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of AVITA Medical Inc?
The top five shareholders of AVITA Medical Inc are:
The Vanguard Group, Inc. holds 1.45M shares, accounting for 5.45% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 1.74M shares, accounting for 6.53% of the total shares.
State Street Investment Management (US) holds 528.78K shares, accounting for 1.99% of the total shares.
Geode Capital Management, L.L.C. holds 618.34K shares, accounting for 2.32% of the total shares.
Northern Trust Investments, Inc. holds 242.03K shares, accounting for 0.91% of the total shares.
The Vanguard Group, Inc. holds 1.45M shares, accounting for 5.45% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 1.74M shares, accounting for 6.53% of the total shares.
State Street Investment Management (US) holds 528.78K shares, accounting for 1.99% of the total shares.
Geode Capital Management, L.L.C. holds 618.34K shares, accounting for 2.32% of the total shares.
Northern Trust Investments, Inc. holds 242.03K shares, accounting for 0.91% of the total shares.
What are the top three shareholder types of AVITA Medical Inc?
The top three shareholder types of AVITA Medical Inc are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
How many institutions hold shares of AVITA Medical Inc (RCEL)?
As of 2025Q3, 206 institutions hold shares of AVITA Medical Inc, with a combined market value of approximately 7.68M, accounting for 25.17% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.05%.
What is the biggest source of revenue for AVITA Medical Inc?
In FY2025Q2, the -- business generated the highest revenue for AVITA Medical Inc, amounting to -- and accounting for --% of total revenue.
